MN Pharmaceuticals achieved highest export sales between January 2014-December 2014 in Turkey and awarded for the performance of becoming No 1 exporter amongst 550 member firms of IMMIB (Istanbul Mineral and Metals Exporters' Association) in pharmaceuticals category.
MN Pharmaceuticals, who has a leading role in the development of Turkish Pharmaceutical industry, have added a new one to its accomplishments. In the 9th ‘Felis Awards’ which was held by MediaCat in digital, creativity, media and PR categories this year, MN Pharmaceuticals won the first prize in ‘The Best Insititutional Identity’ category by its institutional identity concept which was developed for its 90. year celebrations.
The 14th ‘MN Pharmacy Awards’ ceremony was held on May 26 at Rahmi Koc Museum. These awards are presented every other year to support and motivate scientific studies in the field of pharmacy and in which young pharmacists show great interest.
MN Pharmaceuticals, who is the owner of ISO14001 Environment Management System in production site documents since 2007 and who has invested over 5 million US dollars in studies in this field, was awarded with first prize in Environment Friendly Practices category in the 13. Environment Awards Ceremony in which the company was a finalist in two categories.
MN Pharmaceuticals has presented its performance of topics in human rights, labour, environment and anti-corruption with the second UN Global Compact Report and fulfilled its corporate responsibility.
Mustafa Nevzat Pharmaceuticals is the owner of the Golden Mortar in "R/D and Science Award" category in the context of "Drug and Pharmacy Sector Golden Mortar Awards" organized by the Pharmacy periodical.
MN Pharmaceuticals' Sekerpýnar Active Pharmaceutical Ingredient Plant has won the 'Environment Development Award' in 'Kocaeli Chamber of Industry Sehabettin Bilgisu Environment Awards' contest that has been held since 1995.
MN Pharmaceuticals, one of the leader and most established companies of Turkish pharmaceutical industry, has achieved a new accomplishment and earned the Environment Management System Certificate in the scope of TSE ISO 14001 Standards in Active Pharmaceutical Ingredient Plant production.
Production standards of MN Pharmaceuticals, leader company in Turkish pharmaceutical industry, gets approval from the British Ministry of Health, Medicines and Healthcare Products Regulatory Agency, in addition to approval from FDA.
The MN Pharmaceutical Pharmacy Award, given every two years since 1988 by MN Pharmaceuticals, an established and leader company in the pharmaceutical field, is given to Timucin Ugurlu, PhD, Pharm. from Marmara University Faculty of Pharmacy for his thesis named "Directing Pectin-hydroxypropyl Methylcellulose (HPMC) –coated Nicin Tablets to Colon". The award was given to Ugurlu in a ceremony held on Wednesday, May 21, 2008.
MN Pharmaceuticals, one of the leading companies of Turkish pharmaceutical sector, received worldly recognized ISO 14001 Environmental Management System certificate for its manufacturing plants at Yenibosna.
MN Pharmaceuticals performed a ceremony for its first shipment of drugs to USA. An exciting ceremony was held at the MN Yenibosna plants for this shipment which is a first for the Turkish pharmaceutical industry.
Following completion of its inspections at MN Pharmaceuticals, one of the leading companies in the Turkish pharmaceutical field, Food and Drug Administration (FDA) has concluded that the production standards meet the USA standards.
German Federal Republic awarded Dr. Cengiz Sezen, Chairman of MN Pharmaceuticals, with Merit Badge. The Badge, given to Dr. Cengiz Sezen because of his contributions in Turkish-German participations, was presented by the German Ambassador Dr. Eckart Cuntz on behalf of German President Dr. Horst Köhler in a ceremony held in Istanbul.
In addition to our existing telephone number 0212 274 81 50 and fax number 0212 275 79 56, a new telephone line no. 0212 337 38 00 and a new fax line no. 0212 337 38 01 have been put to service.
MN Pharmaceuticals has succesfully undergone a GMP-inspection by the health authorities "Leitstelle Arzneimittelüberwachung Baden-Württemberg", caused by a planned export of medicinal products to Germany.
Information on beta-glucan can be reached directly at Imuneks stand at the IV. Balkan Congress of Immunology in Istanbul on September 5-8th, 2004 in Istanbul, Turkey.
After launching its leading immune system support product "Imuneks" (Beta-Glucan), MN Pharmaceuticals launches Turkey's first healthcare portal about Immunology.
Monthly Meeting: Turkish Society of Cardiovascular Surgery's monthly scientific meeting is held on May 13th, at MN Pharmaceuticals Headquarters.